Skip to main content

Articles

FDA Approvals
Belviq: A New Prescription Weight-Loss Treatment for Overweight or Obese Patients
Read More
Lipid Therapy Update: HDL Therapies Falling Short, Promising LDL Agents, 2 Potential Treatments for Familial Hypercholesterolemia
Read More
New Prognostic Markers in Hypertension Identified
Read More
New Hypertension Guidelines Will Be Strictly Evidence-Based
Read More
Behavioral Interventions Can Result in Weight Loss
Read More
FDA Approvals
First-in-Class Angiotensin Receptor Neprilysin Inhibitor Promising in Heart Failure with Preserved Ejection Fraction
Read More
FDA Approvals
RELAX-AHF: Serelaxin Reduces Dyspnea in Acute Heart Failure
Read More
Cardiometabolic Health
PHS II: Cardiovascular Events in Men Not Reduced with Multivitamins
Read More
Cardiometabolic Health
Interventions for Cardiovascular Risk Reduction in Type 2 Diabetes Must Be Multifactorial
Read More
Cardiometabolic Health
Third Definition of Myocardial Infarction Presented at ESC 2012, Focusing on New High-Sensitivity Biomarkers
Read More
Page 187 of 244
Results 1861 - 1870 of 2436